HAS SYNTHESIS

Welcome to the Brand page for “HAS SYNTHESIS”, which is offered here for Custom manufacture of pharmaceutical products for third parties to order and according to customer requirements;the mark consists of a fanciful design in red and formed by three capital h letters interlocking in the center and the literal elements has synthesis in grey letters, has in all capital letters and synthesis with an initial letter s followed by lower case letters.;pharmaceutical products; chemical preparations for medical use; chemical preparations for pharmaceutical use; chemical-pharmaceutical preparations;the color(s) red and grey is/are claimed as a feature of the mark.;chemical products used for manufacture and production of pharmaceutical preparations;legal research for the pharmaceutical industry; advice regarding intellectual property; intellectual property licensing in the field of chemical and pharmaceutical technology; intellectual property licensing including expertise in the field of chemical and pharmaceutical technology; intellectual property licensing (including pharmaceutical technology know-how);research and development of pharmaceutical products; scientific research in the field of chemical technologies; scientific research in the field of pharmaceutical technologies; engineering, including expertise in the field of chemical and pharmaceutical technology; technical research; quality assessment; chemical analysis; research in the field of chemistry; chemistry services; biological research; conducting of quality control tests; surveying (engineering work); testing of materials; research in the field of physics; scientific and industrial research for the development of medicines and active ingredients; advice in the field of chemical research; industrial research in the field of chemistry; industrial research in the field of pharmaceutical technologies; advice in the field of pharmaceutical technologies;.

Its status is currently believed to be active. Its class is unavailable. “HAS SYNTHESIS” is believed to be currently owned by “HAS Healthcare Advanced Synthesis SA”.